Methotrexate use and alcohol.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 21044443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• “Second Hit” Models of Alcoholic Liver Disease

  2009cited by this paper
• Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens

  2009cited by this paper
• Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

  2009cited by this paper
• Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?

  2008cited by this paper
• Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?

  2008cited by this paper
• Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

  2008cited by this paper
• Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment

  2008cited by this paper
• Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.

  2007cited by this paper
• Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis

  2006cited by this paper
• Monitoring methotrexate‐induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?

  2004cited by this paper
• Alcohol interactions with drugs and its effect on the treatment of skin diseases.

  1999cited by this paper
• Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid.

  1999cited by this paper
• Methotrexate hepatotoxicity.

  1997cited by this paper
• Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.

  1996cited by this paper
• Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines.

  1996cited by this paper
• Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.

  1995cited by this paper
• Cirrhosis in patients with rheumatoid arthritis receiving low dose methotrexate.

  1994cited by this paper
• Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.

  1992cited by this paper
• Methotrexate and histologic hepatic abnormalities: a meta-analysis.

  1991cited by this paper
• Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.

  1989cited by this paper
• Methotrexate hepatotoxicity.

  1984cited by this paper
• Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals.

  1980cited by this paper
• Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals.

  1980cited by this paper
• Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics.

  1978cited by this paper
• Cirrhosis following methotrexate administration for psoriasis.

  1973cited by this paper
• Psoriasis-liver-methotrexate interactions.

  1973cited by this paper
• Cirrhosis caused by methotrexate in the treatment of psoriasis.

  1969cited by this paper
• Cirrhosis following methotrexate administration for psoriasis.

  1969cited by this paper
• Cirrhosis associated with methotrexate treatment of psoriasis.

  1968cited by this paper
• Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists.

  1955cited by this paper

• Do older adults drink alcohol whilst taking alcohol-interactive medication? Prevalence and ten-year mortality risk: findings from the UK Whitehall II cohort study

  2024cites this paper
• Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease

  2023cites this paper
• Development and Validation of an Explainable Machine Learning-Based Prediction Model for Drug–Food Interactions from Chemical Structures

  2023cites this paper
• Methotrexate

  2022cites this paper
• Long-term remission and biologic persistence rates: 12-year real-world data

  2021cites this paper
• Alcohol in Psoriasis—From Bench to Bedside

  2021cites this paper
• Alcohol Use Behaviors and Reasons to Abstain From or Limit Drinking Among Medically Vulnerable Youth.

  2020cites this paper
• Nutrition in RMDs: is it really food for thought? Focus on rheumatoid arthritis

  2020influential citation
• Gaps Exist in the Comprehensive Care of Children with Inflammatory Bowel Diseases.

  2020cites this paper
• How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy

  2019cites this paper
• Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis

  2019cites this paper
• Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study

  2018cites this paper
• Potentiating effect of acetaminophen and carbon tetrachloride-induced hepatotoxicity is mediated by activation of receptor interaction protein in mice

  2018cites this paper
• Non-toxic Level of Acetaminophen Potentiates Carbon Tetrachloride-Induced Hepatotoxicity in Mice.

  2017cites this paper
• The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting

  2017cites this paper
• End‐stage methotrexate‐related liver disease is rare and associated with features of the metabolic syndrome

  2014cites this paper
• Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.

  2014cites this paper
• The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs

  2012cites this paper